Last updated on April 2009

Dose-Reduced Versus Standard Conditioning Prior Allo SCT for MDS/sAML Patients


Brief description of study

The present study is a multicenter, prospective phase III-study comparing dose-reduced versus standard conditioning followed by allogeneic stem cell transplantation from related or unrelated donors in patients with MDS or secondary AML. The hypothesis is that dose-reduced conditioning will reduce the non-relapse mortality from 40% to 20% at one year after allogeneic stem cell transplantation.

Clinical Study Identifier: NCT00682396

Contact Investigators or Research Sites near you

Start Over

Boris Afanassiev, MD

SPb State I. Pavlov Medical University
St. Petersburg, Russian Federation
  Connect »